| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2007-04-12 19:56:15 UTC |
|---|
| Update Date | 2022-03-07 02:49:29 UTC |
|---|
| HMDB ID | HMDB0005998 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 20-Hydroxyeicosatetraenoic acid |
|---|
| Description | 20-Hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid. Cytochrome P450 enzymes of the 4A and 4F families catalyze the omega-hydroxylation of arachidonic acid and produce 20-HETE. 20-HETE is a potent constrictor of renal, cerebral, and mesenteric arteries. The vasoconstrictor response to 20-HETE is associated with activation of protein kinase, Rho kinase, and the mitogen-activated protein (MAP) kinase pathway C. 20-HETE also increases intracellular Ca2+ by causing the depolarization of vascular smooth muscle membrane secondary to blocking the large-conductance Ca2+-activated K+-channels and by a direct effect on L-type Ca channels. Elevations in the production of 20-HETE mediate the myogenic response of skeletal, renal, and cerebral arteries to elevations in transmural pressure. There is an important interaction between nitric oxide (NO) and the formation of 20-HETE production. NO inhibits the formation of 20-HETE formation in renal and cerebral arteries. A fall in levels of 20-HETE contributes to the cyclic GMP-independent dilator effect of NO to activate the large-conductance Ca2+-activated K+-channels and to dilate the cerebral arteries (PMID: 16258232 ). |
|---|
| Structure | OCCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O InChI=1S/C20H32O3/c21-19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-20(22)23/h1,3-4,6-7,9-10,12,21H,2,5,8,11,13-19H2,(H,22,23)/b3-1-,6-4-,9-7-,12-10- |
|---|
| Synonyms | | Value | Source |
|---|
| (5Z,8Z,11Z,14Z)-20-Hydroxyicosa-5,8,11,14-tetraenoic acid | ChEBI | | 20-Hydroxy arachidonic acid | ChEBI | | 20-Hydroxyarachidonic acid | ChEBI | | 20-Hydroxyicosatetraenoic acid | ChEBI | | (5Z,8Z,11Z,14Z)-20-Hydroxyicosa-5,8,11,14-tetraenoate | Generator | | 20-Hydroxy arachidonate | Generator | | 20-Hydroxyarachidonate | Generator | | 20-Hydroxyicosatetraenoate | Generator | | 20-Hydroxyeicosatetraenoate | Generator | | (all-Z)-20-Hydroxy-5,8,11,14-eicosatetraenoate | HMDB | | (all-Z)-20-Hydroxy-5,8,11,14-eicosatetraenoic acid | HMDB | | 20-HETE | HMDB | | 20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoate | HMDB | | 20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid | HMDB | | 20-Hydroxy-5,8,11,14-eicosatetraenoate | HMDB | | 20-Hydroxy-5,8,11,14-eicosatetraenoic acid | HMDB | | 20-Hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoate | HMDB | | 20-Hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | HMDB |
|
|---|
| Chemical Formula | C20H32O3 |
|---|
| Average Molecular Weight | 320.4663 |
|---|
| Monoisotopic Molecular Weight | 320.23514489 |
|---|
| IUPAC Name | (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid |
|---|
| Traditional Name | 20-hete |
|---|
| CAS Registry Number | 79551-86-3 |
|---|
| SMILES | OCCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C20H32O3/c21-19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-20(22)23/h1,3-4,6-7,9-10,12,21H,2,5,8,11,13-19H2,(H,22,23)/b3-1-,6-4-,9-7-,12-10- |
|---|
| InChI Key | NNDIXBJHNLFJJP-DTLRTWKJSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acids and conjugates |
|---|
| Direct Parent | Long-chain fatty acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Long-chain fatty acid
- Hydroxy fatty acid
- Unsaturated fatty acid
- Straight chain fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.96 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 20.6864 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.25 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 34.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3032.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 372.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 188.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 264.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 652.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 973.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 537.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 132.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1988.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 676.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1724.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 726.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 479.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 409.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 432.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 20-Hydroxyeicosatetraenoic acid,1TMS,isomer #1 | C[Si](C)(C)OCCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O | 2826.4 | Semi standard non polar | 33892256 | | 20-Hydroxyeicosatetraenoic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCO | 2608.4 | Semi standard non polar | 33892256 | | 20-Hydroxyeicosatetraenoic acid,2TMS,isomer #1 | C[Si](C)(C)OCCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C | 2694.4 | Semi standard non polar | 33892256 | | 20-Hydroxyeicosatetraenoic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O | 3045.0 | Semi standard non polar | 33892256 | | 20-Hydroxyeicosatetraenoic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCO | 2863.7 | Semi standard non polar | 33892256 | | 20-Hydroxyeicosatetraenoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C | 3184.2 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 20-Hydroxyeicosatetraenoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0007-3290000000-c19c2446fd09c9b5b114 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 20-Hydroxyeicosatetraenoic acid GC-MS (2 TMS) - 70eV, Positive | splash10-0g6s-8958400000-372a8a263c8ea8f0e5b0 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 20-Hydroxyeicosatetraenoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 10V, Positive-QTOF | splash10-0uk9-0059000000-650b772489866747dfc1 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 20V, Positive-QTOF | splash10-0pdr-2293000000-4135e55c1f638956a165 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 40V, Positive-QTOF | splash10-0006-8890000000-7333663b79a20dc52435 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 10V, Negative-QTOF | splash10-014i-0039000000-b8b23d059895b0d51482 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 20V, Negative-QTOF | splash10-0gb9-2098000000-7fd830563f4a43d0b812 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 40V, Negative-QTOF | splash10-0a4l-9040000000-ac722c9b6528d7965c21 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 10V, Negative-QTOF | splash10-014i-0009000000-c55e430e69fa5c79a747 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 20V, Negative-QTOF | splash10-0gb9-1049000000-1b54cbfba7d53b2e17ab | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 40V, Negative-QTOF | splash10-006x-9151000000-9d68be1fa8ed76d657d4 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 10V, Positive-QTOF | splash10-0uk9-1229000000-2c09f1a1c932d016c5e4 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 20V, Positive-QTOF | splash10-0fe1-5934000000-650155a4dedf606f2045 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20-Hydroxyeicosatetraenoic acid 40V, Positive-QTOF | splash10-00lu-7900000000-c13624e44921230c2908 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Hypertension |
|---|
- Minuz P, Jiang H, Fava C, Turolo L, Tacconelli S, Ricci M, Patrignani P, Morganti A, Lechi A, McGiff JC: Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Hypertension. 2008 May;51(5):1379-85. doi: 10.1161/HYPERTENSIONAHA.107.105395. Epub 2008 Mar 31. [PubMed:18378855 ]
| | Cerebral vasospasm |
|---|
- Poloyac SM, Reynolds RB, Yonas H, Kerr ME: Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. J Neurosci Methods. 2005 Jun 15;144(2):257-63. Epub 2004 Dec 30. [PubMed:15910986 ]
|
|
|---|